Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs

Authors:

Abstract
Atrial fibrillation (AF), the most common arrhythmia worldwide, is associated with significant morbidity and increased mortality.1 A major factor in the increase in incidence and prevalence of AF is the obesity epidemic. Although two-thirds of US adults are overweight or obese (body mass index [BMI] >30 [calculated as weight in kilograms divided by height in meters squared]),2 a causal inference between BMI and incident AF was reported only recently in a mendelian randomization study.3

This publication has 35 references indexed in Scilit: